Literature DB >> 6709321

Automated and manual perimetry-a six-year overview. Special emphasis on neuro-ophthalmic problems.

J L Keltner, C A Johnson.   

Abstract

Between August 1976 and September 1982, more than 34,000 manual and automated visual fields have been analyzed in the Department of Ophthalmology, University of California, Davis. Approximately 27% of these tests consisted of manual kinetic visual fields performed on the Goldmann perimeter, while 73% were conducted using automated perimetry. Automated testing alone, or a combination of automated perimetry and manual kinetic testing (Goldmann perimeter) was usually employed to monitor progression or regression of visual field loss. This paper provides an overview of two aspects of automated suprathreshold static perimetry that have not been emphasized in our previous studies: (1) methodologic difficulties and problem patients in automated suprathreshold static perimetry, and (2) examples of automated suprathreshold static perimetry in neuro-ophthalmologic patient populations.

Entities:  

Mesh:

Year:  1984        PMID: 6709321     DOI: 10.1016/s0161-6420(84)34328-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

1.  Use of the neodymium:YAG laser to create iridotomies in monkeys and humans.

Authors:  I P Pollack; A L Robin; D M Dragon; W R Green; H A Quigley; T G Murray; M L Hotchkiss
Journal:  Trans Am Ophthalmol Soc       Date:  1984

2.  Evaluating the usefulness in neuro-ophthalmology of visual field examinations peripheral to 30 degrees.

Authors:  J D Wirtschafter; A L Hard-Boberg; S M Coffman
Journal:  Trans Am Ophthalmol Soc       Date:  1984

3.  Comparative evaluation of Octopus semi-automated kinetic perimeter with Humphrey and Goldmann perimeters in neuro-ophthalmic disorders.

Authors:  Karthika Bhaskaran; Swati Phuljhele; Pawan Kumar; Rohit Saxena; Dewang Angmo; Pradeep Sharma
Journal:  Indian J Ophthalmol       Date:  2021-04       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.